#immunochemistry market | Explore Tumblr posts and blogs

ashwetu · 13 hours ago

Text

Meticulous Research® Unveils New Report: Africa IVD Market Poised to Reach $1.65 Billion by 2031

[Redding, California] — Meticulous Research®, a global leader in market research and consulting, has released a new report titled ‘Africa IVD Market Size, Share, Forecast & Trends Analysis by Offering, Technology (Immunoassay, PoC, Molecular Diagnostics, Coagulation), Application (Infectious Diseases, Diabetes, Oncology), Diagnostic Approach (Lab, OTC, PoCT), End User – Forecast to 2031.’ According to the latest findings, the Africa in vitro diagnostics (IVD) market is projected to grow at a compound annual growth rate (CAGR) of 3.1%, reaching $1.65 billion by 2031.

Download Sample Report Here : https://www.meticulousresearch.com/download-sample-report/cp_id=5415 Market Growth Drivers and Challenges

The expansion of the Africa IVD market is driven by multiple factors, including the rising prevalence of chronic and infectious diseases, increased investments from IVD companies, growing demand for point-of-care (PoC) and rapid diagnostics, and a burgeoning geriatric population. Furthermore, supportive government initiatives aimed at bolstering Africa's healthcare sector and increasing healthcare expenditure are playing a significant role in the market's development.

However, market growth is being restrained by the high costs of advanced IVD products, variations in test results for rapid diagnostics, and the stringent regulatory requirements for high-complexity diagnostic tests. On the other hand, advancements in genomics and proteomics, heightened awareness of early diagnosis, and the increasing adoption of personalized medicine are expected to create significant opportunities for market players. Despite these promising trends, uneven access to healthcare and a shortage of trained healthcare professionals remain critical challenges.

Check complete table of contents with list of table and figures: https://www.meticulousresearch.com/product/africa-ivd-market-5415

Market Segmentation and Key Insights

The report provides detailed insights into the market, segmented by offering, technology, application, diagnostic approach, and end user:

By Offering: The market is segmented into reagents & kits, instruments, and software & services. The reagents & kits segment is expected to grow at the highest CAGR of 3.3% during the forecast period, driven by increased diagnostic test volumes for infectious diseases, particularly malaria and tuberculosis, and various initiatives aimed at improving healthcare access across Africa.

By Technology: In 2024, the immunoassay/immunochemistry segment is projected to account for the largest market share at 34.5%. This is largely due to immunoassay technology's efficient and accurate diagnostics for highly prevalent diseases such as HIV, malaria, and dengue in Africa, along with its cost-effectiveness and continuous development of new biomarkers.

By Application: The infectious diseases segment is expected to dominate the market in 2024, fueled by the widespread prevalence of diseases like COVID-19, dengue, and HIV. Increasing awareness of diagnostic testing and the availability of low-cost rapid test kits are key factors driving this segment’s growth.

Quick Buy: https://www.meticulousresearch.com/Checkout/47708335

By Diagnostic Approach: Point-of-care testing (PoCT) is projected to witness the highest growth during the forecast period, driven by the rising demand for immediate diagnostic results, especially in remote and underserved regions.

By End User: Hospitals and clinics are expected to grow at the highest CAGR between 2024 and 2031. Factors such as the increasing number of hospitalizations for chronic diseases, rising healthcare expenditure, and the willingness of hospitals to adopt advanced diagnostic tools are contributing to this growth.

Geographic Insights

The report also provides an in-depth analysis of various African countries, including South Africa, Nigeria, Egypt, Algeria, Morocco, Kenya, Tunisia, Côte d’Ivoire, Tanzania, Cameroon, and the Rest of Africa. South Africa is projected to grow at the highest CAGR of 8.3% during the forecast period. The growth in South Africa is driven by increased healthcare expenditure, expanded access to diagnostic tools through partnerships and collaborations, and favorable government policies aimed at enhancing healthcare infrastructure.

Competitive Landscape

Key players in the Africa IVD market include Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), bioMérieux SA (France), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), QIAGEN N.V. (Netherlands), Siemens Healthineers AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Illumina, Inc. (U.S.), and Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China). These industry leaders continue to invest in the region, driving innovation and expanding their presence in the African market.

Request Sample PDF Copy Here: https://www.meticulousresearch.com/request-sample-report/cp_id=5415

Key Questions Addressed in the Report:

What is the current revenue generated by IVD products in Africa? What are the projected growth rates for the Africa IVD market over the next 5–7 years? What are the key drivers, opportunities, and challenges affecting this market? Which market segments are generating the most traction in terms of offering, technology, and application? Which countries in Africa offer significant growth opportunities for market participants? Who are the leading players, and what products and strategies are they employing in the Africa IVD market? What recent developments are shaping the competitive landscape?

Contact Information Meticulous Research® Email: [email protected] Phone: +1-646-781-8004 LinkedIn: Connect with us

0 notes

savibangar · 14 days ago

Text

IVD Assay Development Market to be Worth $8.39 Billion by 2031: Size, Share, Forecast, & Trends Analysis

Meticulous Research®, a leading market research firm, has published a new report titled IVD Assay Development Market Size, Share, Forecast, & Trends Analysis by Offering (Assay Development, Packaging Development), Technology (Immunoassay, Molecular Diagnostics, Biochemistry), Application (Oncology, Diabetes) – Global Forecast to 2031. According to the findings, the global IVD assay development market is projected to reach $8.39 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.9% from 2024 to 2031.

Download Research Report Sample @ https://www.meticulousresearch.com/download-sample-report/cp_id=6037

The growth of the IVD assay development market is driven by the increasing prevalence of chronic diseases, a rising geriatric population, the high burden of infectious diseases, and a growing emphasis on the development of point-of-care (POC) IVD assays. Additionally, increasing healthcare expenditures are fueling the demand for more advanced diagnostic solutions. However, the evolving regulatory landscape remains a key challenge to the market’s growth.

Furthermore, emerging economies and advancements in IVD assay technologies present significant growth opportunities for market participants. Challenges related to maintaining product quality and safeguarding proprietary information also pose potential obstacles to market expansion.

Key Players:

The key players profiled in the IVD assay development market report are Thermo Fisher Scientific Inc. (U.S.), Avioq, Inc. (U.S.), Creative Biolabs, Inc (U.S.), Maxim Biomedical, Inc. (U.S.), Bio-Techne Corporation (U.S.), Merck KGaA (Germany), PeploBio Ltd (U.K.), ICON plc (Ireland), NeoDx Biotech Labs Pvt. Ltd. (India), Eclevar Medtech (France), Savyon Diagnostics (Israel), Promega Corporation (U.S.), and Future Diagnostics Solutions B.V. (Netherlands). The market is segmented by offering, technology, and application. The report also provides a comprehensive analysis of market competitors and regional trends.

Browse in depth @ https://www.meticulousresearch.com/product/ivd-assay-development-market-6037

Market Segmentation:

By Offering: In 2024, the IVD assay development services segment is expected to hold the largest share, accounting for 45.1% of the market. This segment encompasses various stages of assay development, including raw material selection, feasibility studies, optimization of assay parameters, and clinical sample testing. The demand for IVD assays in drug discovery, particularly in assessing pharmaceutical candidates and detecting biomarkers, is driving the need for these services. As personalized medicine and precision therapies become more widespread, the demand for high-quality, customized IVD assays continues to rise, further strengthening this segment’s position.

By Technology: The immunoassay/immunochemistry segment is projected to dominate the IVD assay development market in 2024, capturing a share of 42.3%. Immunoassay technologies leverage antigen-antibody reactions to detect causative agents, offering high specificity and throughput. The growing use of immunoassays in point-of-care (PoC) testing for infectious diseases and the increasing global demand for novel assays are driving the segment’s growth. The aging population and the continued innovation in immunoassay formats are additional factors contributing to the dominance of this technology.

By Application: The infectious diseases application segment is anticipated to hold the largest market share in 2024. The rapid spread of infectious diseases makes accurate and early diagnosis crucial to preventing transmission. IVD assays have proven to be essential tools in diagnosing infectious diseases, driving demand for these diagnostic products. Government initiatives, advancements in diagnostic techniques, and recent global outbreaks have heightened awareness and spurred investment in diagnostic solutions. For instance, the World Health Organization (WHO) reported nearly 40 million cases of HIV globally at the end of 2023, up from 25.6 million cases in 2021, further underscoring the need for robust diagnostic tools.

Request Customization Report @ https://www.meticulousresearch.com/request-customization/cp_id=6037

Regional Insights:

The report also provides a detailed regional analysis, highlighting key markets such as North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

By Region: North America is expected to dominate the IVD assay development market in 2024, with a share of 37.8%. This dominance can be attributed to favorable government investments in disease prevention and investigation, a high prevalence of infectious and chronic diseases, a well-established healthcare infrastructure, and a high degree of awareness regarding early disease diagnosis. Furthermore, North America’s early adoption of advanced diagnostic technologies and its strong base of key industry players contribute significantly to the region’s market leadership.

Overall, the IVD assay development market is poised for significant growth, driven by advancements in diagnostic technology, increased healthcare spending, and rising demand for early and accurate disease detection. The report offers valuable insights for stakeholders looking to capitalize on the opportunities in this evolving market.

Download Research Report Sample @ https://www.meticulousresearch.com/download-sample-report/cp_id=6037

#IVD Assay Development Market

0 notes

harshnews · 1 month ago

Text

Professional Diagnostics Market Size, Share, Trends, Growth and Competitive Analysis

"Professional Diagnostics Market – Industry Trends and Forecast to 2029

Global Professional Diagnostics Market, By Product Type (Immunochemistry, Clinical Microbiology, Point Of Care Test (POCT), Haematology And Haemostasis) , End Users (Hospital, Diagnostic Centers, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.

Access Full 350 Pages PDF Report @

The professional diagnostics market is a critical segment of the healthcare industry that plays a fundamental role in diagnosing diseases and medical conditions accurately and efficiently. This market is driven by factors such as the increasing prevalence of chronic diseases, technological advancements in diagnostic devices, growing awareness about early disease detection, and the expanding geriatric population. The global professional diagnostics market is expected to experience significant growth in the coming years due to these factors. The market can be analyzed on the basis of product type, application, and end-users.

**Segments**

- **Product Type**: - Reagents & Kits - Instruments - Data Management Software - Services

- **Application**: - Infectious Diseases - Oncology - Cardiology - Pharmacogenomics - Others

- **End-Users**: - Hospitals - Clinics - Diagnostic Laboratories - Research Institutes

The professional diagnostics market is highly competitive and is characterized by the presence of several key players that offer a wide range of diagnostic products and services. These market players focus on strategic initiatives such as mergers and acquisitions, partnerships, and product innovations to maintain their market position and gain a competitive edge.

**Market Players**

- Roche Diagnostics - Siemens Healthineers - Abbott Laboratories - Danaher Corporation - Thermo Fisher Scientific - Sysmex Corporation - Bio-Rad Laboratories - BioMérieux - Qiagen - Hologic

These market players invest heavily in research and development activities to introduce innovative diagnostic solutions that cater to the evolving healthcare needs of patients and healthcare providers. They also emphasize expanding their global presence through collaborations and partnerships with regional players to enhance their market reach and customer base.

In conclusion, the professional diagnostics market is poised for robust growth due to the increasing demand for accurate and rapid diagnostic solutions. The market is driven by technological advancements, rising healthcare expenditure, and the growing awareness about preventive healthcare measures.The professional diagnostics market is a crucial component of the healthcare industry, with a focus on accurate and efficient disease diagnosis. One of the key drivers propelling the growth of this market is the increasing prevalence of chronic diseases globally. Chronic conditions such as diabetes, cardiovascular diseases, and cancer require timely and precise diagnosis for effective treatment and management. Additionally, the aging population contributes to the demand for diagnostic services, as the elderly are more susceptible to various health issues that necessitate regular monitoring and diagnosis.

Technological advancements in diagnostic devices have revolutionized the way diseases are detected and diagnosed. Innovations such as point-of-care testing, molecular diagnostics, and advanced imaging techniques have significantly improved the accuracy and speed of diagnosis, leading to better patient outcomes. These technological advancements have also paved the way for personalized medicine and precision healthcare, where treatments are tailored to individual patients based on their genetic makeup and specific disease characteristics.

Another driving factor in the professional diagnostics market is the increasing awareness about the importance of early disease detection. Routine screening and diagnostic tests help in the early identification of diseases, enabling prompt intervention and treatment, which can lead to better prognosis and improved quality of life for patients. Governments and healthcare organizations worldwide are investing in awareness campaigns and screening programs to encourage regular health check-ups and early diagnosis, thereby driving the demand for diagnostic services and products.

The professional diagnostics market can be segmented based on product type, application, and end-users, offering a comprehensive view of the diverse offerings in this industry. Reagents & kits, instruments, data management software, and services constitute the product types available in the market, catering to different diagnostic needs and preferences. Applications such as infectious diseases, oncology, cardiology, and pharmacogenomics highlight the wide range of conditions that can be diagnosed using professional diagnostic services. Furthermore, end-users such as hospitals, clinics, diagnostic laboratories, and research institutes represent the diverse settings where diagnostic tests are performed, showcasing the broad reach and impact of this market.

The competitive landscape of the professional diagnostics market is**Global Professional Diagnostics Market, By Product Type (Immunochemistry, Clinical Microbiology, Point Of Care Test (POCT), Haematology And Haemostasis) , End Users (Hospital, Diagnostic Centers, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.**

- The professional diagnostics market is witnessing significant growth and innovation in product types such as Immunochemistry, Clinical Microbiology, Point of Care Test (POCT), Haematology, and Haemostasis. These advancements are crucial in providing accurate and timely diagnostic solutions for a wide range of diseases and medical conditions.

- The end-users of professional diagnostics products and services primarily include hospitals, diagnostic centers, and other healthcare facilities. The increasing demand for diagnostic tests in these settings is driving the growth of the market globally, with a focus on improving patient outcomes and healthcare delivery.

- Geographically, the professional diagnostics market spans across regions such as the U.S., Canada, Mexico, European countries like Germany, Italy, U.K., France, Spain, Netherlands

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Professional Diagnostics Market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Professional Diagnostics Market.

Global Professional Diagnostics Market survey report analyses the general market conditions such as product price, profit, capacity, production, supply, demand, and market growth rate which supports businesses on deciding upon several strategies. Furthermore, big sample sizes have been utilized for the data collection in this business report which suits the necessities of small, medium as well as large size of businesses. The report explains the moves of top market players and brands that range from developments, products launches, acquisitions, mergers, joint ventures, trending innovation and business policies.

The following are the regions covered in this report.

North America [U.S., Canada, Mexico]

Europe [Germany, UK, France, Italy, Rest of Europe]

Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]

South America [Brazil, Argentina, Rest of Latin America]

The Middle East & Africa [GCC, North Africa, South Africa, Rest of the Middle East and Africa]

This study answers to the below key questions:

What are the key factors driving the Professional Diagnostics Market?

What are the challenges to market growth?

Who are the key players in the Professional Diagnostics Market?

What are the market opportunities and threats faced by the key players?

Browse Trending Reports:

Threat Detection Systems Market Pipe Coating Market Fragrance Fixatives Market Mobile Campaign Management Platform Market Menstrual Cramps Treatment Market Roof Insulation Market Mobile Robotics Market Varnish Makers Market Urinary Incontinence Market Treatment Resistant Depression Market Robotic Prosthetics Market Neutropenia Market Polycystic Kidney Disease Adpkd Market Grain Analysis Market Solid State Solar Cell Market Panel Mount Industrial Display Market Automotive Mini Led Market

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC : +653 1251 975

Email: [email protected]"

#Professional Diagnostics Market

0 notes

healthcaremarketresearchsblog · 5 months ago

Text

In-Vitro Diagnostics Market Future Prediction Report By 2030

The Insight Partners recently announced the release of the market research titled In-Vitro Diagnostic Market Outlook to 2030 | Share, Size, and Growth. The report is a stop solution for companies operating in the In-Vitro Diagnostic market. The report involves details on key segments, market players, precise market revenue statistics, and a roadmap that assists companies in advancing their offerings and preparing for the upcoming decade. Listing out the opportunities in the market, this report intends to prepare businesses for the market dynamics in an estimated period.

Is Investing in the Market Research Worth It?

Some businesses are just lucky to manage their performance without opting for market research, but these incidences are rare. Having information on longer sample sizes helps companies to eliminate bias and assumptions. As a result, entrepreneurs can make better decisions from the outset. In-Vitro Diagnostic Market report allows business to reduce their risks by offering a closer picture of consumer behavior, competition landscape, leading tactics, and risk management.

A trusted market researcher can guide you to not only avoid pitfalls but also help you devise production, marketing, and distribution tactics. With the right research methodologies, The Insight Partners is helping brands unlock revenue opportunities in the In-Vitro Diagnostic market.

If your business falls under any of these categories – Manufacturer, Supplier, Retailer, or Distributor, this syndicated In-Vitro Diagnostic market research has all that you need.

What are Key Offerings Under this In-Vitro Diagnostic Market Research?

Global In-Vitro Diagnostic market summary, current and future In-Vitro Diagnostic market size

Market Competition in Terms of Key Market Players, their Revenue, and their Share

Economic Impact on the Industry

Production, Revenue (value), Price Trend

Cost Investigation and Consumer Insights

Industrial Chain, Raw Material Sourcing Strategy, and Downstream Buyers

Production, Revenue (Value) by Geographical Segmentation

Marketing Strategy Comprehension, Distributors and Traders

Global In-Vitro Diagnostic Market Forecast

Study on Market Research Factors

Who are the Major Market Players in the In-Vitro Diagnostic Market?

In-Vitro Diagnostic market is all set to accommodate more companies and is foreseen to intensify market competition in coming years. Companies focus on consistent new launches and regional expansion can be outlined as dominant tactics. In-Vitro Diagnostic market giants have widespread reach which has favored them with a wide consumer base and subsequently increased their In-Vitro Diagnostic market share.

Report Attributes

Details

Segmental Coverage

Product & Service

Reagents & Kits

Instruments

Software & Services

Technology

Immunoassay/ Immunochemistry

Clinical Chemistry

Molecular Diagnostics

Microbiology

Blood Glucose Self-Monitoring

Coagulation Hemostasis

Hematology

Urinalysis

Others

Application

Infectious Diseases

Diabetes

Oncology

Cardiology

Autoimmune Diseases

Nephrology

Others

End User

North America

Europe

Asia Pacific

the Middle East & Africa

South & Central America

and Geography

Regional and Country Coverage

North America (US, Canada, Mexico)

Europe (UK, Germany, France, Russia, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, Australia, Rest of APAC)

South / South & Central America (Brazil, Argentina, Rest of South/South & Central America)

Middle East & Africa (South Africa, Saudi Arabia, UAE, Rest of MEA)

Market Leaders and Key Company Profiles

Abbott Laboratories?

F. Hoffmann-La Roche Ltd?

Danaher Corp?

Siemens AG?

Sysmex Corp?

Thermo Fisher Scientific Inc

Becton Dickinson and Co

bioMerieux SA?

Bio-Rad Laboratories Inc

Qiagen NV

Other key companies

What are Perks for Buyers?

The research will guide you in decisions and technology trends to adopt in the projected period.

Take effective In-Vitro Diagnostic market growth decisions and stay ahead of competitors

Improve product/services and marketing strategies.

Unlock suitable market entry tactics and ways to sustain in the market

Knowing market players can help you in planning future mergers and acquisitions

Visual representation of data by our team makes it easier to interpret and present the data further to investors, and your other stakeholders.

Do We Offer Customized Insights? Yes, We Do!

The The Insight Partners offer customized insights based on the client’s requirements. The following are some customizations our clients frequently ask for:

The In-Vitro Diagnostic market report can be customized based on specific regions/countries as per the intention of the business

The report production was facilitated as per the need and following the expected time frame

Insights and chapters tailored as per your requirements.

Depending on the preferences we may also accommodate changes in the current scope.

Author’s Bio:

Sunil Jadhav

Senior Market Research Expert at The Insight Partners

0 notes

in-vitro-diagnostics-market · 1 year ago

Text

Top 5 Prominent Companies Shaping the In Vitro Diagnostics Market

The IVD market is driven by growing demand for point-of-care devices and rapid diagnostic testing, increasing prevalence of chronic diseases, and increasing willingness to pay for preventive care testing.

The global in vitro diagnostics market in terms of revenue was estimated to be worth $117.8 billion in 2022 and is poised to reach $138.4. billion by 2027, growing at a CAGR of 3.3% from 2022 to 2027.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=703

The prominent players in the IVD market are.

Roche diagnostics

Roche is a global pioneer in IVD focused on developing novel products with advanced research capabilities. The combined strengths of diagnostics & automation and growing expertise in personalized healthcare help the company acquire a prominent market share. The company’s differentiated product portfolio in infectious diseases, tissue diagnostics, oncology, and diabetes management, makes the company a leading player in the IVD market. Being a research-driven biotechnology company, Roche Diagnostics extensively invests in R&D. For instance, the company’s R&D expenditure accounted for USD 14.99 billion in 2021.

2. Danaher corporation

Danaher Corporation has established itself as a strong player in the IVD market. The company offers a wide array of products and services sold regularly through direct sales channels to a diverse customer base in more than 60 countries. As a multibillion-dollar global conglomerate, Danaher generates a large proportion of its sales in North America, Europe, and Asia/Australia.

During 2021, the Diagnostics segment experienced higher year-over-year sales for molecular diagnostics tests for COVID-19. Moreover, in 2021, core sales in the segment’s clinical lab business increased year-over-year across all major geographies, driven primarily by increased demand in the chemistry and immunoassay product lines. Additionally, in the same year, core sales in the molecular diagnostics business grew yearly in both developed and high-growth markets, contributing significantly to overall segment core sales growth. Sales in 2021 for the company’s diagnostics segment by region included-- 44% in North America, 19% in Western Europe, 5% in other developed markets, and 32% in high-growth markets.

3. ABBOTT LABORATORIES, INC.

Abbott Laboratories is a leading player in the IVD market. The company has a strong presence in the US and seeks to enhance its geographical presence by strengthening its business operations in emerging markets. The company has a strong product portfolio, and its FDA- and CE-approved products have helped it gain a sizable share of the IVD market. Abbott is presently focusing on developing next-generation instrument platforms, such as the PLEX-ID platform and other advanced patient self-testing technologies.

4. SIEMENS HEALTHINEERS

Siemens Healthineers is among the leading players in the IVD market. The company has a strong presence and scale and is directly represented in more than 70 countries worldwide, with primary production sites in the US, China, and Germany. Siemens provides a comprehensive array of IVDs spanning a breadth of test settings, from centralized reference and hospital laboratories to clinical and physician office laboratories. The company’s diagnostics business model is based on long-term contracts that include an initial instrument placement followed by ongoing reagent sales, which results in a predictive and resilient revenue stream.

In FY 2022, the company’s revenue increased notably across all segments on a comparable basis: Imaging by 5.8%, Varian by 6.5%, Advanced Therapies by 5.7%, and Diagnostics by 6.6%, including around USD 1.77 billion from rapid COVID-19 antigen tests.

5. SYSMEX CORPORATION

Sysmex’s business centers on IVD, especially hematology, urinalysis, and immunochemistry products. The company’s business spans over 190 countries. In IVD, Sysmex Corporation holds the 7th rank globally, the only top-10 company headquartered in Asia. Sysmex is a global leader in hematology products, holding more than 50% of the global hematology market.

Get 10% Free Customization on this Report: - https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=703

These five companies collectively shape the IVD market by consistently delivering innovative diagnostic solutions, playing a pivotal role in healthcare, and addressing the evolving diagnostic needs of patients and healthcare professionals.

#In Vitro Diagnostics #IVD #ivdmarket #healthcare

1 note · View note

trendingreports-07 · 1 year ago

Text

North America Immunochemistry Market Size, Growth Analysis and Global Outlook 2019 to 2027

This report is the market consists of a detailed description and analysis based on the various types of products are available in a wide range of end-user summaries on other markets North America Immunochemistry Market, it has introduced a new report titled. This report includes an analysis of the impact of the COVID-19 pandemic. The report offers a complete and analytical look at various companies striving to achieve high market shares in the North America Immunochemistry Market. This report includes various drivers as well as factors impeding the growth of this market during the forecast period. The report presents the market opportunities and a tangible impact on the key players dominating the market.

"The North America immunochemistry market is expected to reach US$ 1,536.87 Mn in 2027 from US$ 806.34 Mn in 2018. The market is estimated to grow with a CAGR of 7.6% from 2019-2027."

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis:

North America Immunochemistry includes Market Analysis Report Top Companies:

• PerkinElmer, Inc. • Abcam Plc • Agilent Technologies, • Bio SB • Bio-Rad Laboratories, Inc. • Cell Signalling Technology, Inc. • F. Hoffmann-La Roche Ltd. • Danaher • Merck KGaA • Thermo Fisher Scientific, Inc.

The rising advancements in biotechnology have increased the demand for diagnostics in the healthcare market, encouraging the introduction of a more significant number of immunoassay systems and facilitating the shift toward personalized medicine. There are new opportunities in infectious disease testing, molecular oncology, and pharmacogenomics in emerging countries. Hence, healthcare companies can target patients or consumers in developing nations.

North America Immunochemistry Market Segmentation:

North America Immunochemistry Market -By Types

• Antibodies • Equipment • Reagents • Kits

North America Immunochemistry Market Application Outlook:

• Diagnostics • Drug Testing

North America Immunochemistry Market: Competitive Landscape

This section of the report identifies various key manufacturers in the market. It helps the reader understand the strategies and collaborations that players are focusing on combatting competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the regional revenue of manufacturers, during the forecast period.

Browse the report description and TOC:

Key Features of the Report and North America Immunochemistry Market Highlights:

• Comprehensive assessment of all opportunities and risks in the regional market. • North America Immunochemistry market recent innovations and major events. • Detailed study of business strategies for growth of the North America Immunochemistry market-leading players. • Conclusive study about the growth plot of the North America Immunochemistry market for forthcoming years. • In-depth understanding of North America Immunochemistry market -particular drivers, constraints, and major micro-Markets. • Favourable impression of vital technological and market latest trends striking the North American Immunochemistry market.

North America Immunochemistry Market Research Report 2019-2027:

• Chapter 1: Industry Overview • Chapter 2: North America Immunochemistry Market International and Regional market Analysis • Chapter 3: Environment Analysis of market. • Chapter 4: Analysis of Revenue by Classifications. • Chapter 5: Analysis of Revenue by Regions and Applications. • Chapter 6: Analysis of North America Immunochemistry Market Revenue Market Status. • Chapter 7: Analysis of Industry Key Manufacturers • Chapter 8: Sales Price and Gross Margin Analysis of market. • Chapter 9: ……………………. Continue to TOC

Finally, the report presents market information in the most comprehensive manner. The report structure has been maintained to provide maximum business value. It provides critical insight into market dynamics and enables strategic decision-making for established market participants and those willing to enter the market.

Immediate delivery of our off-the-shelf reports and prebooking of upcoming studies, through flexible and convenient payment methods:

*If you need anything more than these then let us know and we will prepare the report according to your requirement.

About Us:

Business Market Insights is a market research platform that provides subscription services for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.

If you have any questions about this report or would like further information, please contact us:

Contact person: Ankit Mathur

Email: [email protected]

Phone: +16467917070

0 notes

ashwetu · 14 hours ago

Text

Meticulous Research® Unveils New Report: Africa IVD Market Poised to Reach $1.65 Billion by 2031

Download Sample Report Here : https://www.meticulousresearch.com/download-sample-report/cp_id=5415 Market Growth Drivers and Challenges

Check complete table of contents with list of table and figures: https://www.meticulousresearch.com/product/africa-ivd-market-5415

Market Segmentation and Key Insights

The report provides detailed insights into the market, segmented by offering, technology, application, diagnostic approach, and end user:

Quick Buy: https://www.meticulousresearch.com/Checkout/47708335

Geographic Insights

Competitive Landscape

Request Sample PDF Copy Here: https://www.meticulousresearch.com/request-sample-report/cp_id=5415

Key Questions Addressed in the Report:

Contact Information

Meticulous Research® Email: [email protected] Phone: +1-646-781-8004 LinkedIn: Connect with us

0 notes

neha24blog · 2 years ago

Text

Molecular Cytogenetics Market Outlook On The Basis Of Application, Product, End Use, Technology, Region And Forecast to 2025: Grand View Research Inc.

San Francisco, 28 April 2023: The Report Molecular Cytogenetics Market Analysis Report By Application (Oncology, Personalized Medicine), By Product, By End Use, By Technology (FISH, Immunochemistry, Karyotyping), And Segment Forecasts, 2018 – 2025 The global molecular cytogenetics market size is expected to reach USD 3. 8 billion by 2025, according to a new report by Grand View Research, Inc.,…

View On WordPress

#Molecular Cytogenetics Industry #Molecular Cytogenetics Market #Molecular Cytogenetics Market 2025 #Molecular Cytogenetics Market Revenue #Molecular Cytogenetics Market Share #Molecular Cytogenetics Market Size

0 notes

sanjay-chem · 2 years ago

Text

Immunohistochemistry Market Size, Share, Demand, Growth & Trends by 2032

As per Future Market Insights' latest industry analysis, the immunohistochemistry market size is expected to be worth US$ 2.05 billion in 2022 and US$ 4.59 billion by 2032, with a quick CAGR of 8.4% between 2022 and 2032.

Adoption of immunohistochemistry is anticipated to increase as a result of the rise in healthcare spending and the spike in interest in living a higher quality life.

The immunohistochemistry market outlook is anticipated to expand due to the increase in chronic diseases. As value-based healthcare solutions are becoming more popular, it is anticipated that the demand for immunohistochemistry is likely to increase rapidly.

The immunohistochemistry market share is expected to increase due to an increase in patients with cancer, infectious diseases, and cardiovascular disorders, all of which use immunohistochemistry for diagnosis.

Get a Sample PDF Copy of Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14808

The alarming rate at which infectious diseases are spreading presents a challenge for medical professionals in developing drugs for such unidentified diseases. The rise in demand for immunohistochemistry for such diseases is expected to drive immunohistochemistry market growth.

According to the International Diabetes Federation, 463 million people aged 20 to 79 worldwide have diabetes as of 2019, with that figure expected to rise to nearly 700 million by 2045.

Increased R&D in immunohistochemistry-based techniques is expected to drive immunohistochemistry market growth in the coming years.

Additionally, the adoption of immunohistochemistry is estimated to grow over the course of the projected period due to an increase in the incidence and prevalence of chronic diseases like cancer, where proteins are expected to play a significant role. Short-term expansion of the immunohistochemistry industry is expected to be constrained by unfavorable reimbursement regulations.

Key Takeaways from Market Study

Since antibodies play such an important role in disease diagnosis and medication testing, the antibodies segment dominated the immunochemistry market in 2021, accounting for more than 41% of global revenue.

The diagnostics application sector accounted for approximately 70% of revenue in 2021, and it is expected that this segment is projected to lead during the forecast period.

In 2021, hospitals and diagnostic laboratories generated more than 71% of total revenue, dominating the immunochemistry market.

North America is likely to dominate the immunochemistry market in 2021, accounting for more than 39% of global sales.

Asia Pacific is expected to have the fastest CAGR during the forecast period. This is largely due to global players increased geographic presence in Asian markets.

"Increasing automation and machine learning deployment in immunohistochemistry (IHC), as well as the release of technologically enhanced IHC solutions, are expected to significantly drive the immunohistochemistry market share during the forecast period. Due to advancements in IHC methods, the demand for immunohistochemistry in disease diagnosis has increased significantly."- Future Market Insights Analyst.

Competitive Landscape

Key players in the immunohistochemistry market are developing cutting-edge products that are expected to drive immunohistochemistry market growth.

The introduction of these clinical diagnostic markers could help the immuno-oncology field advance early cancer medication development. The immunohistochemistry market is expected to expand at a faster rate during the forecast period due to R&D advancements.

The following companies are among the major players in the global immunohistochemistry market: Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Merck KGaA; Danaher Corporation; PerkinElmer, Inc., Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., Bio SB; Abcam plc., Agilent Technologies, Inc.

Browse Full Report: https://www.futuremarketinsights.com/reports/immunohistochemistry-market

Key Segments

By Product:

Primary Antibodies

Secondary Antibodies

Slide Staining System

Tissue Microarrays

Tissue Processing Systems

Slide Scanners

Others

Histological stains

Blocking Sera and Reagents

Chromogenic Substrates

Fixation Reagents

Stabilizers

Organic Solvents

Proteolytic Enzymes

Diluents

By Application:

Cancer

Infectious Diseases

Cardiovascular Diseases

Autoimmune Diseases

Diabetes Mellitus

Nephrological Diseases

By End-use:

Hospitals & Diagnostic Laboratories

Research Institutes

Others

By Region:

North America

Latin America

Europe

Asia Pacific

MEA

Recent Developments in Immunohistochemistry Market:

Roche's VENTANA MMR RxDx companion diagnostic test was approved by the FDA in August 2021 for solid tumours that lack the MMR pathway. The test determines who is eligible for JEMPERLI, GSK's anti-PD1 immunotherapy.

Agilent received a CE-IVD mark in Europe in August 2021 for its PD-L1 IHC 22C3 pharmDx assay for the identification of oesophageal cancer patients for treatment with KEYTRUDA.

Biocare Medical LLC introduced the ONCORE Pro, a fully automated in vitro diagnostic benchtop system for In-situ Hybridization (ISH) and IHC applications, in January 2021.

In January 2021, Abcam and Shuwen Biotech (Shuwen) formed a strategic partnership to develop and market Companion Diagnostics (CDx). According to the agreement, Abcam will provide recombinant rabbit monoclonal antibodies to Shuwen Biotech for additional immunohistochemistry.

0 notes

kanewarner · 2 years ago

Link

0 notes

jean-perry · 2 years ago

Text

0 notes

digitalgenral · 2 years ago

Text

0 notes

chemicaltech · 2 years ago

Text

in vitro diagnostics quality control Market Pegged for Robust Expansion by 2031 | Type, Application, Scope & Key Companies

The global in vitro diagnostics quality control market was valued at USD 1.5 billion in 2021 and it is anticipated to grow further up to USD 2.2 billion by 2031, at a CAGR of 3.7% during the forecast period.

The effectiveness of in vitro diagnostic tests, including those for pathogen identification using in vitro nucleic acid testing, healthcare-associated illnesses (HAIs) such as pneumonia, urinary tract infections, and others, is assessed using IVD quality controls. These products primarily concentrate on defect detection, quality control, and validation panels like the Blood Culture (BCID) Control Panel, Human Papillomavirus (HPV) Control Panel, and others to support in the implementation and monitoring of the performance of clinical and research laboratories, blood diagnostic centers, and IVD manufacturers.

To Remain 'Ahead' Of Your Competitors, Request for A Sample – https://www.globalinsightservices.com/request-sample/GIS10301

Major Players in the Global In Vitro Diagnostic Quality Control Market

The key players studied in the global in vitro diagnostic quality control market are Bio-Rad Laboratories, Inc. (US), Randox Laboratories Ltd. (UK), Thermo Fisher Scientific, Inc. (US), LGC Limited (UK), Abbott Laboratories (US), Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Fortress Diagnostics (UK), SERO AS (US), Sysmex Corporation (Japan), Ortho-Clinical Diagnostics (US), and Helena Laboratories Corporation (US) among others.

Global In Vitro Diagnostics Quality Control Market Segmentation

By Product & Service

Quality Control Products

Data Management Solutions

Quality Assurance Services

By Technology

Immunochemistry

Clinical Chemistry

Molecular Diagnostics

Microbiology

Hematology

Coagulation/Hemostasis

Market Trends and Drivers

As the burden of various diseases increases globally, so has the number of laboratory tests. The number of laboratories in both the public and private sectors has increased in response to this need. With the start of the COVID-19 pandemic in December 2019, the demand for diagnostic tests has skyrocketed. Many government organizations have established new laboratories in response to this epidemic and to increase laboratory testing capacity. The majority of nations need clinical laboratories to get regulatory body accreditation before performing diagnostic tests. Additionally, accreditation to ISO 15189:2012 and other comparable standards is turning into a requirement in many nations. Authorities assess a laboratory’s competency and quality system during the accreditation process using predetermined standards. While some European nations, including Belgium, France, Hungary, Ireland, and Lithuania, require accreditation for a variety of laboratory tests, others, like Finland, the Netherlands, Sweden, Switzerland, and the UK, have practically finished the process.

With Global Insight Services, you receive:

· 10-year forecast to help you make strategic decisions

· In-depth segmentation which can be customized as per your requirements

· Free consultation with lead analyst of the report

· Excel data pack included with all report purchases

· Robust and transparent research methodology

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm

headquartered in Delaware, US. We are committed to providing our clients

with highest quality data, analysis, and tools to meet all their market research

needs. With GIS, you can be assured of the quality of the deliverables, robust

and transparent research methodology, and superior service.

Global Insight Services LLC

16192, Coastal Highway, Lewes DE 19958

E-mail: [email protected]

Phone: +1-833-761-1700

0 notes

healthcaremreports · 2 years ago

Link

#Immunochemistry Reagents Market

0 notes

ashwetu · 3 months ago

Text

Meticulous Research® Unveils New Report: Africa IVD Market Poised to Reach $1.65 Billion by 2031

Meticulous Research®, a global leader in market research and consulting, has released a new report titled ‘Africa IVD Market Size, Share, Forecast & Trends Analysis by Offering, Technology (Immunoassay, PoC, Molecular Diagnostics, Coagulation), Application (Infectious Diseases, Diabetes, Oncology), Diagnostic Approach (Lab, OTC, PoCT), End User – Forecast to 2031.’ According to the latest findings, the Africa in vitro diagnostics (IVD) market is projected to grow at a compound annual growth rate (CAGR) of 3.1%, reaching $1.65 billion by 2031.

Download Sample Report Here : https://www.meticulousresearch.com/download-samplereport/cp_id=5415

Market Growth Drivers and Challenges

Check complete table of contents with list of table and figures:

Market Segmentation and Key Insights

The report provides detailed insights into the market, segmented by offering, technology, application, diagnostic approach, and end user:

Quick Buy: https://www.meticulousresearch.com/Checkout/47708335

Geographic Insights

Competitive Landscape

Key players in the Africa IVD market include Abbott Laboratories (U.S.), Becton, Dickinson and

Company (U.S.), bioMérieux SA (France), Danaher Corporation (U.S.), F. Hoffmann-La Roche

Ltd (Switzerland), QIAGEN N.V. (Netherlands), Siemens Healthineers AG (Germany), Thermo

Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Illumina, Inc. (U.S.), and Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China). These industry leaders continue to invest in the region, driving innovation and expanding their presence in the African market.

Request Sample PDF Copy Here: https://www.meticulousresearch.com/request-samplereport/cp_id=5415

Key Questions Addressed in the Report:

What is the current revenue generated by IVD products in Africa?What are the projected growth rates for the Africa IVD market over the next 5–7 years?What are the key drivers, opportunities, and challenges affecting this market?Which market segments are generating the most traction in terms of offering, technology, and application?Which countries in Africa offer significant growth opportunities for market participants? Who are the leading players, and what products and strategies are they employing in the Africa IVD market?What recent developments are shaping the competitive landscape?

Contact Information

Meticulous Research®

Email: [email protected]

Phone: +1-646-781-8004

LinkedIn: Connect with us

0 notes